BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10575919)

  • 41. Treatment of severe aplastic anemia using HLA-non-identical family donors.
    Trigg ME
    Am J Pediatr Hematol Oncol; 1991; 13(1):1-2. PubMed ID: 2029071
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of severe aplastic anemia (SAA) by bone marrow transplantation (BMT) or immunosuppression?].
    Höcker P; Hinterberger W; Gadner H; Hajek-Rosenmayr A; Fischer-Hinterberger M; Kos M; Emminger W; Panzer S; Lechner K
    Beitr Infusionther Klin Ernahr; 1987; 18():329-31. PubMed ID: 3326592
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.
    Huang XJ; Chen YH; Xu LP; Zhang YC; Liu DH; Guo NL; Lu DP
    Chin Med J (Engl); 2004 Apr; 117(4):604-7. PubMed ID: 15109458
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bone marrow transplantation in the treatment of aplastic anemia patients].
    Fedorovskaia NA; Svedentsov EP; Sharygin SL; Epifanov NS
    Ter Arkh; 1993; 65(3):92-5. PubMed ID: 8059398
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
    Storb R; Blume KG; O'Donnell MR; Chauncey T; Forman SJ; Deeg HJ; Hu WW; Appelbaum FR; Doney K; Flowers ME; Sanders J; Leisenring W
    Biol Blood Marrow Transplant; 2001; 7(1):39-44. PubMed ID: 11215697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Syngeneic bone marrow transplantation for treatment of aplastic anaemia: report of a case and review of the literature.
    Lu DP
    Exp Hematol; 1981 Mar; 9(3):257-63. PubMed ID: 7014237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes of bone marrow MRI pattern in aplastic anemia before and after bone marrow transplantation].
    Masumoto A; Yonekura S; Ogawa Y; Fukuda R; Fujiwara H; Watanabe S; Satoh H; Kawada H; Umeda Y; Mishima K
    Rinsho Ketsueki; 1993 Nov; 34(11):1494-6. PubMed ID: 8254913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
    Dulley FL; Vigorito AC; Aranha FJ; Sturaro D; Ruiz MA; Saboya R; Macedo MC; Da Silva RL; Chamone DA; Mehta J; Bacigalupo A; De Souza CA
    Bone Marrow Transplant; 2004 Jan; 33(1):9-13. PubMed ID: 14578930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved survival in severe acquired aplastic anemia of childhood.
    Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
    Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.
    Viollier R; Socié G; Tichelli A; Bacigalupo A; Korthof ET; Marsh J; Cornish J; Ljungman P; Oneto R; Békássy AN; Fuehrer M; Maury S; Schrezenmeier H; van Lint MT; Wojcik D; Locasciulli A; Passweg JR
    Bone Marrow Transplant; 2008 Jan; 41(1):45-50. PubMed ID: 17982502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of graft-versus-host disease in allogeneic bone marrow transplantation.
    Nakamura H; Teshima H; Hiraoka A; Shibata H; Inoue T; Masaoka T
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1627-33. PubMed ID: 3328949
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of acquired aplastic anaemia.
    Marsh JC
    Blood Rev; 2005 May; 19(3):143-51. PubMed ID: 15748962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
    Oblon DJ; Weiner RS; Mackin PJ
    J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
    [No Abstract]   [Full Text] [Related]  

  • 60. [Aplastic anemia].
    Dorantes S; de la Soledad Córdova M; Pizzuto J; Gónzalez Llaven J
    Gac Med Mex; 1989; 125(11-12):341-60. PubMed ID: 2699298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.